跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利伐沙班干混悬剂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rivaroxaban for Suspension
Approved
化学药品
Rivaroxaban for Suspension
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
Apr 29, 2022
Approval ID
8GAHvaT32pF
Company
BAYER AG
Type
化学药品
Approval Details
Approval Id
8GAHvaT32pF
Approval Number
国药准字HJ20220045
Generic Name
利伐沙班干混悬剂
Generic Name En
Rivaroxaban for Suspension
Drug Type
化学药品
Dosage Form
干混悬剂
Strength
51.7mg
Reg Date
2022-04-29
Expired Date
2027-04-28
Company Name
BAYER AG
Company Address
51368 Leverkusen, Germany
Production Company Name
BAYER AG
Production Company Address
Kaiser-Wilhelm-Allee, 51368 Leverkusen, Germany
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/bayer-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 29, 2022
Approval ID
8GAHvaT32pF
Type
化学药品
Back to NMPA Approvals